DUBLIN--(BUSINESS WIRE)--The "Global Molecular Diagnostics Market: Industry Analysis & Outlook (2018-2022)" report has been added to ResearchAndMarkets.com's offering.
The report offers an in-depth analysis of the Global Molecular Diagnostics Market. It covers the regional and global aspect of the market. Competition is concentrated in the hands of few major companies.
Molecular diagnostics market is escalating beyond the identification of infections. It is becoming an essential part of disease management and therapy. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The market is further expected to see a robust growth with increased research and development.
The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which will instigate the growth of the molecular diagnostics technology in the future, thereby posing tremendous growth potential for the market.
The key factors driving growth of the MD market includes fast approvals for companion diagnostics reagents, increase in emergence of infectious disease, innovation and technical development, rising ageing population, and escalating global healthcare expenditure.
However, there are certain factors hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper healthcare infrastructure.
The major trends featuring the market include progressing sample-to-answer molecular diagnostics market, growth in Point of Care Diagnostics (POCT), and emergence of Liquid Biopsy Solutions among others.
Market Dynamics
Growth Drivers
- Fast Approvals for Companion Diagnostics (CD) Reagents
- Rising Emergence of Infectious Diseases
- Rise in Global Ageing Population
- Increasing Incidence of Cancer Cases
- Rising Global Healthcare Expenditure
Key Trends & Developments
- Progressing Sample-to-Answer Molecular Diagnostics Market
- Growth in Point of Care Diagnostics (POCT)
- Booming Medical Devices Industry
- Innovation and Technical Developments
- Emergence of Liquid Biopsy Solutions
- Targeting Anti-Biotic Resistance
- Decentralization of Diagnostic Testing
Challenges
- High Initial Cost
- Obligation of Skilled Labor
- Urgent Need for Proper Infrastructure
Topics Covered
1. Overview
2. Global In-Vitro Diagnostics (IVD) Market
3. Global Molecular Diagnostics Market
4. Regional Market Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company Profiles
- Abbott Laboratories
- Danaher Corporation
- Hologic Inc.
- Roche Holding AG
For more information about this report visit https://www.researchandmarkets.com/research/sq5jmn/global_molecular?w=4
